{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibyklkuf7swdzook6rd3a6l5dpsjg4q47ibracazvuha7q3epcc7e",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mmimojbuqaw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreife4ft24agekmm5vu5h2plsx6khf33p2s36odtp2fgdg65od4x3ly"
    },
    "mimeType": "image/jpeg",
    "size": 81219
  },
  "path": "/2026/05/22/retro-biosciences-longevity-valuation/?utm_campaign=rss",
  "publishedAt": "2026-05-22T11:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "aging",
    "biotechnology",
    "Pharmaceuticals",
    "STAT+",
    "STAT Summit"
  ],
  "textContent": "Retro Biosciences, the longevity startup backed by OpenAI CEO Sam Altman, has raised more money at a $1.8 billion valuation, it announced Friday.",
  "title": "STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion",
  "updatedAt": "2026-05-22T14:08:13.000Z"
}